BetterLife Pharma (BETRF) Research & Development (2011 - 2026)
BetterLife Pharma (BETRF) posted Research & Development of $15685.8 for Q2 2026, up 1265.83% on a QoQ basis from $1148.4 in Q3 2025, and up 63.85% year-over-year from $9573.3 in Q2 2025.
Powered by 
Analysis
BetterLife Pharma (BETRF) Research & Development (2011 - 2026) Analysis & Trends
BetterLife Pharma has reported Research & Development for 11 years, with the latest figure at $15685.8 in Q2 2026.
- On a quarterly basis, Research & Development rose 63.85% year-over-year to $15685.8 in Q2 2026; TTM through Apr 2026 was $48839.3, a 79.2% decrease from a year earlier, with the FY2026 full-year figure at $61534.7, down 80.03% from the prior year.
- Research & Development was $15685.8 for Q2 2026 at BetterLife Pharma, up from $1148.4 in the prior quarter.
- The five-year high for Research & Development was $1.5 million in Q2 2022, with the low at $1148.4 in Q3 2025.
- Average Research & Development over 5 years is $210796.6, with a median of $91574.3 recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Research & Development soared 448.77% in 2022, then slumped 99.42% in 2025.
- Over 5 years, Research & Development stood at $19479.7 in 2022, then soared by 405.44% to $98458.4 in 2023, then slumped by 94.51% to $5400.6 in 2024, then plunged by 78.73% to $1148.4 in 2025, then soared by 1265.83% to $15685.8 in 2026.
- The last three Research & Development figures came in at $15685.8 (Q2 2026), $1148.4 (Q3 2025), and $9573.3 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.87 Bn |
| 2 | Gilead Sciences | 180.02 Bn | 176.84 Bn | 6.22 Bn | 1.76 Bn |
| 3 | Vertex Pharmaceuticals | 131.54 Bn | 123.69 Bn | 2.84 Bn | 993.80 Mn |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.96 Bn | 3.93 Bn | 1.63 Bn |
| 5 | Argenx Se | 60.23 Bn | 55.04 Bn | 1.37 Bn | -486.00 Mn |
| 6 | Moderna | 53.85 Bn | 48.72 Bn | 52.00 Mn | 651.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.13 Bn | 29.82 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Biogen | 31.88 Bn | 30.59 Bn | 1.96 Bn | 529.60 Mn |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | 202.02 Mn |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - | 15,685.84 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 15,685.84 |
| Jul 31, 2025 | 1,148.45 |
| Apr 30, 2025 | 9,573.27 |
| Jan 31, 2025 | 22,431.77 |
| Oct 31, 2024 | 5,400.63 |
| Jul 31, 2024 | 197,393.83 |
| Apr 30, 2024 | 84,690.19 |
| Jan 31, 2024 | 137,587.46 |
| Oct 31, 2023 | 98,458.38 |
| Jul 31, 2023 | 138,452.11 |
| Apr 30, 2023 | 49,253.93 |
| Jan 31, 2023 | 318,262.83 |
| Oct 31, 2022 | 19,479.66 |
| Jul 31, 2022 | 238,557.76 |
| Apr 30, 2022 | 1.51 Mn |
| Jan 31, 2022 | 524,118.03 |
| Oct 31, 2021 | 949,250.78 |
| Jul 31, 2021 | 1.82 Mn |
| Apr 30, 2021 | 1.05 Mn |
| Jan 31, 2021 | -150,277.94 |